Clinical Trial: NCT00005584
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 3| Lead Sponsor: | European Organisation for Research and Treatment of Cancer - EORTC |
| Information Provided By: | European Organisation for Research and Treatment of Cancer - EORTC |
| Last Update Posted: | 2025-08-05 |
Study Overview
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells. It is not yet known which combination chemotherapy regimen is most effective in treating Hodgkin's lymphoma.
PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy with or without radiation therapy in treating patients who have Hodgkin's lymphoma.
Official Title
Conditions
Intervention / Treatment
- Biological: bleomycin sulfate
- Drug: ABVD regimen
- Drug: BEACOPP regimen
- Drug: epirubicin hydrochloride
- Drug: prednisone
- Drug: vinblastine sulfate
- Radiation: radiation therapy
Other Study ID Numbers
- EORTC-20982
- FRE-FNCLCC-98014
- GELA-H9
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | European Organisation for Research and Treatment of Cancer - EORTC |
| Information Provided By: | European Organisation for Research and Treatment of Cancer - EORTC |
| Last Update Posted: | 2025-08-05 |
Study Overview
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells. It is not yet known which combination chemotherapy regimen is most effective in treating Hodgkin's lymphoma.
PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy with or without radiation therapy in treating patients who have Hodgkin's lymphoma.
Official Title
Conditions
Intervention / Treatment
- Biological: bleomycin sulfate
- Drug: ABVD regimen
- Drug: BEACOPP regimen
- Drug: epirubicin hydrochloride
- Drug: prednisone
- Drug: vinblastine sulfate
- Radiation: radiation therapy
Other Study ID Numbers
- EORTC-20982
- FRE-FNCLCC-98014
- GELA-H9